Our Partners
Regenerative Medicine
Our Regenerative Medicine Division specialises in a range of efficacious products that support healing and rejuvenation across many areas of wellness and healthy ageing.
Through collaboration with global partners, we strive to bring pioneering advancements in the restoration, repair, and rejuvenation of damaged cells to New Zealand. Our innovative technologies aim to revolutionise treatments to support the enhancement of health and vitality in patients. Our portfolio boasts a renowned cosmeceutical skincare range, plant-based exosomes to assist skin regeneration and hair restoration, Platelet-Rich Plasma (PRP) supporting skin rejuvenation, hair restoration, and the tissue and joint healing process, and varicose and spider vein treatment solutions.
asap
Australia's number one cosmeceutical skincare range, asap products have been developed to suit the unique environmental conditions of Australia and New Zealand. For over two decades, asap has provided effective skincare solutions for all skin types, addressing sun damage, ageing, and acne with active ingredients like AHAs, Vitamin C, Vitamin A, and antioxidants. Complementing the skincare is the asap pure mineral makeup, combining natural ingredients with the latest advances in skin technology, asap pure delivers sheer, flawless coverage, SPF15 and anti-pollution protection and beautiful luminosity for all skin types.
Estar Medical
Globally recognised as the leading provider of a patented platform method to produce Autologous Platelet Rich Plasma (PRP), we proudly represent the Estar Tropocells® and Cellenis® products. Utilising a patient’s own blood derived plasma, PRP supports growth factors and healing properties for skin rejuvenation, hair restoration, and tissue and joint healing. This cutting-edge technology has indications in multiple disciplines including dermatology, aesthetics, orthopaedics, sports medicine, wound care, pain management, dental, ophthalmology, veterinary and more.
STD Pharmaceuticals
In collaboration with Kreussler Pharma, STD Pharmaceuticals produce, market, and distribute Fibrovein, a detergent based sclerosant licensed for the treatment of varicose veins. Occluding veins by the process of sclerosis, the aim is to promote the production of maximum endothelial damage with subsequent minimal thrombus formation aiding fibrosis of the treated vein.
AngioDynamics
With a product portfolio focused on assisting healthcare professionals safely, efficiently and effectively managing their patients’ health and well-being, Angio Dynamics are the market leader in endovenous laser ablation treatments (EVLT) and the first company to use diode lasers in vein management. AngioDynamics knows the technology and clinical efficacy of EVLT like no one else, and delivers cutting-edge products and support tailored to your needs and those of your patient’s seeking treatment for varicose veins.